Trametinib response in heavily pretreated high-grade ovarian cancer: One step towards precision medicine

Traditional treatment failure in recurrent ovarian cancer remains a challenge for clinicians. Tumor genetic testing is a promising tool which has been proved able to identify sensitivity profiles in patients affected by cancers. This may be helpful in choosing targeted systemic treatments, aiming to...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Gynecol Oncol Rep
Asıl Yazarlar: Cappuccio, Serena, Distefano, Maria Grazia, Ghizzoni, Viola, Fagotti, Anna, Scambia, Giovanni
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2020
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7042411/
https://ncbi.nlm.nih.gov/pubmed/32128357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gore.2020.100547
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller